Late clinical outcome of coronary stenting in diabetic patients;Influencia de la diabetes mellitus en los resultados clínicos tardíos de la revascularización coronaria con stents

Revista Espanola de Cardiologia

Volumn 54, Issue 3, 2001, Pages 261-268

  Pascual Figal, Domingo A ^a   Valdés Chávarri, Mariano ^a,b   García Almagro, Francisco ^a   Garzón Rodríguez, Alfredo ^a   González Carrillo, Josefa ^a   García Alberola, Arcadio ^a   Soria Arcos, Federico ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b NONE   (Spain)

Author keywords

Coronary disease; Diabetes mellitus; Stenting

Indexed keywords

ARTICLE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HUMAN; MALE; MIDDLE AGED; RISK FACTOR; STENT; TIME;

CORONARY DISEASE; DIABETES COMPLICATIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; RISK FACTORS; STENTS; TIME FACTORS;

EID: 0035292770     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0300-8932(01)76307-5     Document Type: Article

References (31)

1. Frein FS, Scheuer J. Heart disease in diabetes. En: Rifkin H, Porte D Jr, editores. Ellenberg and Rifkin's. Diabetes Mellitus Theory and Practice. Nueva York, NY: Elsevier Science Publishing Corp., 1990; 812-823.
2. Kannel WB, McGee DL. Diabetes and cardiovascular disease: the Framingham Study. JAMA 1979; 241: 2035-2038.
3. Weintraub WS, Stein B, Gebhart SP, Craver JM, Jones EL, Guyton RA. The impact of diabetes on the initial and long-term outcomes of coronary artery bypass surgery [resumen]. Circulation 1995; 92 (Supl 1): 643.
4. The Bypass Angioplasty Revascularization Investigators (BARI). Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease. Circulation 1997; 96: 1761-1769.
5. O'Neill WW. Multivessel balloon angioplasty should be abandoned in diabetic patients. J Am Coll Cardiol 1998; 31: 20-22.
6. Aronson D, Bloomgarden Z, Rayfield EJ. Potential mechanisms promoting restenosis in diabetic patients. J Am Coll Cardiol 1996; 27: 528-535.
7. Kornowski R, Mintz GS, Kent KM, Pichard AD, Satler LF, Bucher TA et al. Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. A serial intravascular ultrasound study. Circulation 1997; 95: 1366-1369.
8. Stein B, Weintraub WS, Gebhart SSP, Cohen-Bernstein CL, Grosswald R, Liberman HA et al. Influence of diabetes mellitus on early and late outcome after percutaneous transmural coronary angioplasty. Circulation 1995; 91: 979-989.
9. Kip KE, Faxon DP, Detre KM, Yeh W, Kelsey SF, Currier JW, for the Investigators of the NHLB) PTCA Registry. Coronary angioplasty in diabetic patients. Circulation 1996; 94: 1818-1925.
10. Van Belle E, Bauters C, Hubert E, Bodart JC, Abolmaali K, Meurice T et al. Restenosis rates in diabetic patients. A comparison of coronary stenting and balloon angioplasty in native coronary vessels. Circulation 1997; 96: 1454-1460.
11. Bauters C, Hubert E, Prat A, Bougrimi K, Van Belle E, McFadden EP et al. Predictors of restenosis after coronary stent implantation. J Am Coll Cardiol 1998; 31: 1291-1298.
12. Ellis SG, Savage M, Fischman D, Baim DS, Leon M, Goldberg S et al. Restenosis after placement of Palmaz-Schatz stents in native coronary arteries. Initial results of a multicenter experience. Circulation 1992; 86: 1836-1844.
13. Navarro LF, Iñiguez A, Ibargollin R, García R, Fernández I, Rodríguez RC. Comparison of clinical and angiographic outcome of diabetic vs non-diabetic patients treated with conventional angioplasty vs stent implantation in native coronary artery. Rev Esp Cardiol 2000; 53: 172-178.
14. Savage MP, Fischman DL, Slota P, Rake R, Leon M, Schatz R et al. Coronary intervention in the diabetic patient: Improved outcome following stent implantation versus balloon angioplaty [resumen]. J Am Coll Cardiol 1997; 29 (Supl A): 188.
15. Kastrati A, Schömig A, Elezi S, Schühlen H, Dirschinger J, Hadamitzky M et al. Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol 1997; 30: 1428-1436.
16. Carrozza JP Jr, Kuntz RE, Fischman RF, Baim DS. Restenosis after arterial injury caused by coronary stenting in patients with diabetes mellitus. Ann Intern Med 1993; 118: 344-349.
17. Carrozza JP Jr, Schatz RA, George CJ, Leon MB, King SB III, Hirshfeld JW, for the NACI investigators. Acute and long-term outcome after Palmaz-Schatz stenting: analysis from the New Approaches to Coronary Intervention (NACI) Registry. Am J Cardiol 1997; 80: 78K-88K.
18. Elezi S, Kastrati A, Pache J, Wehinger A, Hadamitzky M, Dirschinger J et al. Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement. J Am Coll Cardiol 1998; 32: 1866-1873.
19. Schofer J, Schluter M, Rau T, Hammer F, Haag N, Mathey DG. Influence of treatment modality on angiograhic outcome after coronary stenting in diabetic patients: a controlled study. J Am Coll Cardiol 2000; 35: 1554-1559.
20. Hoffmann R, Mintz GS, Dussaillant GR, Popma JJ, Pichard AD, Satler LF et al. Patterns and mechanisms of in-stent restenosis: a serial intravascular ultrasound study. Circulation 1996; 94: 1247-1254.
21. Chobanian AV. Influence of hypertension and of antihypertensive drugs on the arterial wall. Clin Physiol Biochem 1988; 6: 201-209.
22. Clowes AW, Clowes MM. Influence of chronic hypertension on injured and uninjured arteries in spontaneously hypertensive rats. Lab Invest 1980; 43: 535-541.
23. Schiffrin SL, Intengan HD, Thibault G, Touyz RM. Clinical significance of endothelin in cardiovascular disease. Curr Opin Cardiol 1997; 12: 54-367.
24. Ribichini F, Steffenino G, Dellavalle A, Matullo G, Colajanni E, Camilla T et al. Plasma activity and insertion/deletion polymorphism of angiotensin I-converting enzyme: a major risk factor and a marker of risk for coronary stent restenosis. Circulation 1998; 97: 147-154.
25. Guarda E, Fajuri A, Marchant E, Martínez A, Jalil J, Illanes G et al. D/D genotype of the gene for angiotensin converting enzyme is a risk factor for post-stent coronary restenosis. Rev Esp Cardiol 2000; 52: 475-480.
26. Lau KW, Ding AP, Johan A, Lim YL. Midterm angiographic outcome of single-vessel intracoronary stent placement in diabetic versus nondiabetic patients: a matched comparative study. Am Heart J 1998; 136: 150-155.
27. Elezi S, Kastrati A, Neumann FJ, Hadamitzky M, Dirschinger J, Schömig A et al. Vessel size and long-term outcome after coronary stent placement. Circulation 1998; 98: 1875-1880.
28. Abizaid A, Kornowski R, Mintz GS, Hong MK, Abizaid AS, Mehran R et al. The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol 1998; 32: 584-589.
29. Joseph T, Fajadet J, Jordan Ch, Cassagneau B, Laborde JC, Laurent JP et al. Coronary stenting in diabetics: Immediate and mid-term clinical outcome. Cathet Cardiovasc Intervent 1999; 47: 279-284.
30. Serruys PW, Sousa E, Belardi J, Nobuyoshi M, Probst P, Gulba DC et al. BENESTENT-II trial: subgroup analysis of patients assigned either to angiographic and clinical follow-up or clinical follow-up alone [resumen]. Circulation 1997; 96 (Supl 1): 653.
31. Kimura T, Nosaka H, Yokoi H, Iwabuchi M, Nobuyoshi M. Serial angiographic follow-up after Palmaz-Schatz stent implantation: Comparison with conventional balloon angioplasty. J Am Coll Cardiol 1993; 21: 1557-1563.